Document Detail


Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.
MedLine Citation:
PMID:  23264359     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: To perform cardiovascular risk stratification in patients with inflammatory joint diseases (IJD) and treat to lipid targets according to recommendations. METHODS: We initiated a preventive cardio-rheuma clinic based on the unmet need of adequate cardiovascular prevention in IJD patients. A full cardiovascular risk stratification was performed at the first consultation (history of conventional risk factors and of cardiovascular disease, lipid measurement, blood pressure and ultrasound examination of both carotid arteries), and the patient was classified to either a primary or secondary cardiovascular prevention regime, or to have a low risk (no intervention). Lipid-lowering treatment was adjusted until at least two lipid targets were achieved. RESULTS: Of the 426 patients referred, 36.6% had a systematic coronary risk evaluation less than 5% (no lipid-lowering intervention). The remaining 270 patients ((rheumatoid arthritis (RA), n=165; ankylosing spondylitis (AS), n=70; and psoriatic arthritis (PsA), n=35) were assigned to either primary (n=63) or secondary prevention (n=207). There were significant differences between the patient groups regarding age (p<0.001), sex (p<0.001) and disease duration (p<0.001). Lipid changes in IJD patients were: total cholesterol -1.86±1.20 mmol/l (p<0.001); low-density lipoprotein cholesterol -1.74±1.11 (p<0.001); high-density lipoprotein cholesterol 0.01±0.30 (p=0.61); triglycerides -0.28±0.72 (p<0.001). The proportions of patients reaching at least two lipid targets were for RA 92.1%, AS 90.0% and PsA 82.9%. No serious adverse events were observed. CONCLUSIONS: There was indication for cardiovascular prevention in a high proportion of IJD patients referred for cardiovascular risk stratification. Treatment to lipid targets was successful in approximately 90% of patients with IJD.
Authors:
Silvia Rollefstad; Tore K Kvien; Ingar Holme; Anne S Eirheim; Terje R Pedersen; Anne Grete P Semb
Related Documents :
6274169 - Relationship between circulating immune complexes and angiotensin-converting enzyme in ...
7449809 - Pericardial involvement in asymptomatic patients undergoing long-term hemodialysis: an ...
9093879 - Levels of interleukin-8 in tuberculous pleurisy and the profile of immunocompetent cell...
7313339 - Sarcoidosis or extrinsic allergic alveolitis?
1115469 - Hemorrhagic pleural effusion in patients undergoing chronic hemodialysis.
24197589 - Intravenous lipid emulsion in wide complex arrhythmia with alternating bundle branch bl...
18558369 - Treatment of neuroblastoma with human natural antibodies.
2035049 - Communicating probabilistic information to cancer patients: is there 'noise' on the line?
22203929 - Evaluation of serum and gingival crevicular fluid c-reactive protein and il-6 levels in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-22
Journal Detail:
Title:  Annals of the rheumatic diseases     Volume:  -     ISSN:  1468-2060     ISO Abbreviation:  Ann. Rheum. Dis.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372355     Medline TA:  Ann Rheum Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studi...
Next Document:  A plea for end-of-life discussions with patients suffering from Huntington's disease: the role of th...